BCL2 and Miyoshi myopathy: Moreover, PD-L1+ RPMI8226 cells have higher Bcl-2 and FasL expression compared with PD-L1− RPMI8226 cells and PDL-1 upregulation is associated with drug resistance, higher MM cell percentages in BM, and higher serum lactate dehydrogenase levels [148].